 Home > Biochemistry News > Biotechnology News > Cervical cancer patients reduce the risk of death by 31% PD-1 inhibitors receive FDA priority review

Cervical cancer patients reduce the risk of death by 31% PD-1 inhibitors receive FDA priority review

 Last Update: 2021-10-10
 Source: Internet
 Author: User

Tags

3 8 1 4

wart skin cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 28, 2021, Regeneron announced that the US FDA has granted priority to the supplementary biological product license application (sBLA) for the PD-1 inhibitor Libtayo (cemiplimab) jointly developed by the company and Sanofi.

Cervical cancer is the fourth leading cause of cancer deaths in women in the world, and it most often occurs in women aged 35-44

Libtayo is a PD-1 inhibitor jointly developed by Sanofi and Regeneron

This application is based on the support of the results of a phase 3 clinical trial.

The FDA is expected to respond to this application before January 30, 2022

Reference materials:

[1] FDA Accepts Libtayo® (cemiplimab-rwlc) for Priority Review for Advanced Cervical Cancer.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.